Michael C. Kaufmann, CEO, Pharmaceutical Segment at CARDINAL HEALTH INC (CAH), sold 10,143 shares at $45.95 ($466K) on 2011-07-01, disclosed to the SEC on 2011-07-05.
Scheduled sale ($466k) by CEO, Pharmaceutical Segment under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CAH | SELL | 2014-02-11 | $26.2M | — | Filing → |
| CAH | SELL | 2013-05-23 | $2K | — | Filing → |
| CAH | SELL | 2013-01-25 | $2.6M | — | Filing → |